Breast cancer in women younger than 35 years : features and outcomes in the breast unit at Aristide le Dantec Teaching Hospital, Dakar

Gueye, Mamour; Gueye, S M; M, Gueye; Dia, Fatimata; Gassama, Omar; Diallo, Moussa; Moreau, Jean Charles

doi:10.1684/mst.2016.0637

Cited by 6 publications

(16 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Five-year survival rates from breast cancer in low and middle income countries (LMICs) are estimated at 57% [20]. In SSA countries, breast cancer survival estimates are available for Ethiopia, The Gambia, Nigeria, South Africa and Uganda [4–6;21–23], and for young patients (<35 years) from Senegal [24]. Comparisons with these studies are hindered by methodological differences and limitations of the individual studies.…”

Section: 0 Discussionmentioning

confidence: 99%

Breast cancer survival in Soweto, Johannesburg, South Africa: A receptor-defined cohort of women diagnosed from 2009 to 11

Cubasch

Dickens

Joffe

et al. 2018

Cancer Epidemiology

View full text Add to dashboard Cite

In this South African cohort, breast cancer survival is suboptimal, but was better for early stage and hormone receptor-positive tumours. Efforts to reduce clinic losses in the immediate post-diagnosis period, in addition to early presentation and accelerated diagnosis and treatment, are needed to prevent breast cancer deaths, and survival improvements need to be monitored using prospective studies with active follow-up.

show abstract

Section: 0 Discussionmentioning

confidence: 99%

Breast cancer survival in Soweto, Johannesburg, South Africa: A receptor-defined cohort of women diagnosed from 2009 to 11

Cubasch

Dickens

Joffe

et al. 2018

Cancer Epidemiology

View full text Add to dashboard Cite

show abstract

“…This average age is slightly higher than that reported in African literature for young women. Darre et al in 2017 in Togo, Bonane-Thieba et al in 2010 in Burkina-Faso, Bouzid et al in 2013 in Tunisia, and Gueye et al in 2016 in Senegal had respectively found an average age of 32.6 years, 31, 3 years, 30.9 years and 29.7 years [4][5][6][7][8]. The average age of cancer in young women in Cotonou is comparable to data from Western authors.…”

Section: Agementioning

confidence: 56%

“…The mean age of the patients in our study was 25.7±7.2 years. In Senegal in 2016, Gueye et al found 25 years as the average age of benign breast tumors with 70% of patients under 30 years [6]. Patients under the age of 30 represented 84.6% of our study population.…”

Section: Agementioning

confidence: 66%

Epidemiological and Anatomopathological Characteristics of Breast Tumors in Young Women in Cotonou in the Republic of Benin from 2015 to 2019

Patrice¹,

Ogoudjobi²,

Aboubakar³

et al. 2021

JGO

View full text Add to dashboard Cite

Objective: Study the epidemiological and anatomopathological characteristics of breast tumors of young woman.Patients and Methods: This was a retrospective and evaluative cross-sectional study of patients treated for a breast tumor between January 1, 2015 and December 31, 2019 in two hospitals in Cotonou. All the complete files of patients under the age of 40 treated for breast tumors of whatever nature were listed. The patients were recalled for clinical and / or radiological evaluation. The epidemiological and histological characteristics of breast tumors were analyzed. Results: The study involved 231 breast tumors including 12 cancers (5.2%) and 219 benign tumors (94.8%). The mean age of the patients was 25.7 years±7.2. Self-examination was the most common discovery (81%). The average consultation time was 6.4 months. The right breast and the upper-external quadrant were the most affected in 53% and 31.1%, respectively. Fibroadenomas (70.7%) and invasive ductal carcinomas (9/12) were the most frequent. Obesity and a family history of breast cancer were associated with the occurrence of breast cancer in young women (p ≤ 5%). The relative risk of developing breast cancer was practically zero before the age of 30. Benign breast tumors spontaneously regressed in part or in whole in 35.3% of cases (n=55), they were stable in 44.8% of cases (n=70) and increased in volume in 19.8% of cases (n=31). The age of diagnosis strongly influenced the evolution of tumors in the young woman in Cotonou (p=0.02). In 56% of cases, breast tumors diagnosed before the age of 20 spontaneously resolved in part and in whole. The breast cancer case fatality in women under 40 was 11.1%. Conclusion: Breast tumors in young women are mostly benign. More than half of these tumors diagnosed before the age of 20 resolve spontaneously. The risk of breast cancer is virtually zero before the age of 30 in our series.

show abstract

“…Male breast cancers represented 2.05% [32]. In Senegal, between 2007 and 2015, the incidence of women younger under 35 years old with breast cancer was 22.6% [33]. Always, in Senegal, a retrospective and prospective study from 2010 through June 2014, found 188 women patients met the inclusion criteria.…”

Section: Breast Cancersmentioning

confidence: 99%

“…87.1% of patients received chemotherapy and 62.9% were operable by surgery. Recurrence more occurred and mean survival was 36.7 months [33]. Breast cancer occurs in young women, who had their first menses after 12 years, are premenopausal, had their first pregnancy before the age of 30, and breastfed for several months [34].…”

Section: Senegal and Togomentioning

confidence: 99%

Epidemiological Situation and Medical Management of Gynaecological and Breast Cancers from 1998 to 2018 in West Africa: A Systematic Review

Zoure¹,

Bayala²,

Bambara³

et al. 2020

Asian Pac J Cancer Biol

View full text Add to dashboard Cite

Objective: Gynaecological cancers are public health diseases and contribute to the global burden of diseases. In West Africa most have been carried out on all gynaecological and breast cases to describe the epidemiological features and management modalities.Methods: Our research covered a period from 1998 to 2018. The terms “gynaecological cancers” and “West Africa”; are used to find records in the research databases (PubMed, ScienceDirect, Scopus and Google Scholar). There are countries (Cape Verde, Guinea, Gambia, Liberia, Sierra Leone) in which we have not found any work in the research databases. The process for selecting studies followed selection steps based on PRISMA 2009. Result: Cervical cancer is the commonest, followed by breast cancer, ovarian cancer, uterine or endometrial cancers, vaginal cancer and vulvar cancer. The lowest common was tubal cancers. The two English-speaking countries, Nigeria and Ghana, recorded 60 (60.82%) and 16 (15.68%) articles published respectively. At the same time, these two countries reported the most cases of gynaecological cancers including 72,848 cases (68.97%), 12, 327 cases (11.67%) and 12, 021 cases (11.38%) for Nigeria, Cote d’Ivoire and Ghana respectively. West Africa countries are characterised by poor outcome due to ignorance, superstition, self-denial, late presentation and unavailability of treatment facilities. Conclusion: Our study suggests that comprehensive national health insurance schemes as well as preventive strategies, patient and health work force education may improve the current situation. Also, West African countries must necessarily have a policy of acquiring the technical platforms to carry out these diagnostic and prognostic examinations.

show abstract

Breast cancer in women younger than 35 years : features and outcomes in the breast unit at Aristide le Dantec Teaching Hospital, Dakar

Cited by 6 publications

References 0 publications

Breast cancer survival in Soweto, Johannesburg, South Africa: A receptor-defined cohort of women diagnosed from 2009 to 11

Breast cancer survival in Soweto, Johannesburg, South Africa: A receptor-defined cohort of women diagnosed from 2009 to 11

Epidemiological and Anatomopathological Characteristics of Breast Tumors in Young Women in Cotonou in the Republic of Benin from 2015 to 2019

Epidemiological Situation and Medical Management of Gynaecological and Breast Cancers from 1998 to 2018 in West Africa: A Systematic Review

Contact Info

Product

Resources

About